Ipsen to Move U.S. Research Center to Cambridge 10/29/2013Posted by Morse, Barnes-Brown Pendleton in Client News.
Tags: biopharmaceuticals, ipsen, research center
On September 26, MBBP client Ipsen, Inc., a French drug company, announced that its U.S. research center is moving into a new 62,600-square-foot space in Cambridge, Massachusetts. The move will be a big change from being in the suburbs, where Ipsen has been headquartered for more than 35 years. The new space will be about 50 percent bigger than the 43,000-square-foot building it occupied in Milford, Massachusetts. Ipsen, which has 4,900 employees worldwide, specializes in drugs for life threatening diseases including oncology, endocrinology and neuromuscular disorders.